Basic-helix-loop-helix (bHLH) proteins are transcriptional regulatory proteins that govern cell fate determination and differentiation in a variety of tissues. We have identified a novel bHLH protein, named Pod-1, that belongs to a recently-described subfamily of bHLH proteins that have essential roles in the embryonic development of mesodermal tissues. In the adult human and mouse, Pod-1 was most highly expressed in the kidney, lung and heart. In developing mouse embryos, Pod-1 was selectively expressed in mesenchymal cells at sites of epithelial-mesenchymal interaction in the kidney, lung, intestine and pancreas. Pod-1 was also expressed in visceral glomerular epithelial cells (podocytes) in the kidney, and its expression coincided with the onset of podocyte differentiation. The expression of Pod-1 in embryonic kidney explants was inhibited using antisense oligonucleotides. Inhibition of Pod-1 expression resulted in decreased mesenchymal cell condensation around the ureteric bud and a 40% decrease in ureteric branching. Pod-1 is the first tissue-restricted basic-helixloop-helix protein that has been identified in the developing kidney where it may play a role in the regulation of morphogenetic events.
Introduction
The definitive kidney in mammals, the metanephros, arises from two distinct embryonic anlagen that are both derived from intermediate mesoderm, the ureteric bud and the metanephric mesenchyme (Saxén, 1987) . The ureteric bud is the primordium of the renal collecting system which consists of the collecting ducts, calyces, pelvis and ureter. The nephron proper consisting of the glomerulus, proximal tubule, loop of Henle and distal tubule is derived from the metanephric mesenchyme. The development of the metanephros exemplifies the importance of epithelial-mesenchymal interactions in organogenesis (Saxén and Thesleff, 1992; Birchmeier and Birchmeier, 1993; Thesleff et al., 1995) . During metanephric development, reciprocal inductive interactions exist between the ureteric bud epithelium and metanephric mesenchymal cells. Branching morphogenesis of the renal collecting system is dependent on inductive signals from the surrounding metanephric mesenchyme (Grobstein, 1955) . Conversely, the tips of the ureteric bud induce nephrogenic mesenchymal cells to undergo a mesenchymal-to-epithelial transformation forming glomerular and tubular epithelial cells of the nephron (Saxén, 1987) . At the molecular level, a number of soluble factors have been identified that are important for these interactions including hepatocyte growth factor, transforming growth factor b, bone morphogenetic proteins, and members of the Wnt family of signaling molecules (Stuart et al., 1995; Thesleff et al., 1995; Ekblom, 1996) . Epithelial-mesenchymal interactions in the developing kidney also involve cell adhesion molecules and extracellular matrix components (Birchmeier and Birchmeier, 1993) . During nephrogenesis, the genes encoding these proteins must be developmentally regulated. However, only a few transcription factors have been shown to be essential for kidney development (Dressler, 1995; Ekblom, 1996) . In addition, little is known regarding the genetic factors that specify the mesenchymal and epithelial cell lineages in the developing kidney.
Basic-helix-loop-helix (bHLH) proteins are transcriptional regulatory proteins that govern cell fate determination and differentiation in a variety of tissues Murre et al., 1994) . Members of the bHLH family include the myogenic protein, MyoD, and the related proteins myogenin, Myf-5, and MRF4. These proteins activate muscle-specific genes when ectopically expressed in a variety of non-muscle cell types and induce a conversion to a skeletal muscle phenotype including formation of contractile complexes and multinucleated myotubes (Davis et al., 1987; Edmondson and Olson, 1989) . This property led to the designation of MyoD as a 'master control gene' that was responsible for initiating a genetic regulatory cascade that resulted in skeletal muscle differentiation. Recent gene targeting experiments have shown that these proteins, alone or in concert, are essential for skeletal muscle formation (Hasty et al., 1993; Rudnicki et al., 1993) . The capacity for cell determination is not restricted to the myogenic lineage since neurogenic bHLH proteins, e.g. NeuroD and neurogenin, can induce neuronal differentiation in surface ectoderm (Lee et al., 1995; Ma et al., 1996) . Other bHLH proteins are involved in the embryonic development of the heart (Srivastava et al., 1995) or somites (Burgess et al., 1996) and tissue-specific gene expression (Naya et al., 1995) . bHLH proteins contain an evolutionarily conserved 50-amino-acid domain consisting of two amphipathic ahelices separated by a variable loop adjacent to a sequence that is highly enriched in basic amino acids Murre et al., 1994) . The helix-loop-helix region mediates protein dimerization, whereas the basic region mediates sequence-specific DNA binding. Most bHLH proteins recognize a DNA sequence that contains a core CANNTG motif (E-box) that was first identified in the immunoglobulin heavy chain gene enhancer (Murre et al., 1994) . In general, bHLH proteins can be grouped into four classes : (1) class A proteins (e.g. E12, E47 and HEB) are expressed ubiquitously, (2) class B proteins (e.g. MyoD, NeuroD) are expressed in specific cell types, (3) Id proteins lack a basic region and function as dominant negative inhibitors of class A and class B proteins, (4) Hairy and Enhancer-of-split [h/E(spl)] proteins contain an invariant proline in the basic region, bind to an N-box sequence (CANNAG), and inhibit promoter activity. Most class B proteins preferentially bind to DNA as heterodimers with class A proteins and function as transcriptional activators (Murre et al., 1989b; Hollenberg et al., 1995) . Although class A and Id proteins are expressed in the developing kidney (Roberts et al., 1993; Duncan et al., 1994; Jen et al., 1996) , no tissue-restricted (class B) bHLH proteins have previously been reported in the metanephros. As will be described below, we have recently cloned a novel mesoderm-specific bHLH protein, named Pod-1, that is expressed in mesenchymal and glomerular epithelial cells in the kidney. Considering the important role of bHLH proteins in cell differentiation, Pod-1 is likely to be an important regulator of kidney morphogenesis.
Results

cDNA cloning of mouse and human Pod-1
To identify cell-type-specific bHLH proteins in human fetal kidney, we performed a text search of the expressed sequence tag (EST) databases. These databases contain partial nucleotide sequences of uncharacterized transcripts that are expressed in known tissues, including the kidney. The search criteria were designed to identify bHLH proteins that were novel and that were expressed in the kidney. We identified a partial-length human cDNA in the Institute for Genome Research database that fulfilled these criteria. The sequence of the EST (accession no. R65626) did not match any known gene in the GenBank database. Complete sequencing of the EST clone indicated that it encoded a bHLH protein that was similar to other mesodermallyexpressed bHLH proteins. Because the transcript was highly expressed in podocytes (see below), we have named this gene Pod-1. A homologous cDNA (W08124) that contained the 3′ end of the mouse transcript was identified in the dbEST database. The full-length mouse cDNA was amplified from neonatal kidney using anchored PCR, and the sequence information that was obtained was then used to design PCR primers for amplifying a full-length human cDNA from a fetal kidney library.
The human Pod-1 cDNA was 1251 bp and consisted of 260 bp of 5′ untranslated region, 537 bp of coding region, and 454 bp of 3′ untranslated region (the nucleotide sequences of mouse and human Pod-1 have been deposited in the GenBank database with accession numbers AF035717 and AF035718, respectively). The cloned sequence terminated in a poly(A) tail that was preceded by a consensus polyadenylation signal. The initiation codon was selected based on the presence of a Kozak consensus sequence and an upstream in-frame termination codon. The open reading frame was predicted to encode a protein consisting of 179 amino acids with an estimated molecular weight of 19 700 and a pI of 9.34 (Fig. 1) . The predicted protein contained a 57-amino-acid bHLH domain from amino acids 78-134 that conformed to the consensus sequence described by Murre et al. (1989a) (Fig. 2) . In particular, Pod-1 contains the invariant basic region sequence EXXR which is a determinant of E-box recognition . Near the amino-terminus of Pod-1, there was a sequence (amino acids 8-45) in which 13 of 38 residues (34%) were aspartate or glutamate. Amino terminal domains that are relatively enriched in acidic amino acids have previously been identified in other transcription factors where they function as transcriptional activation domains. Between the acidic domain and the bHLH domain there was a sequence (amino acids 51-66) that was highly enriched in basic amino acids and may constitute a nuclear localization signal. The remainder of the sequence of Pod-1 was not similar to any known proteins. The amino acid sequences of mouse and human Pod-1 were 95% identical (92% within the amino-terminal domain, 100% within the bHLH domain, and 96% within the carboxyl-terminal domain) which indicated that the two genes were orthologous. Fig. 2 shows the alignment of the bHLH domain of Pod-1 with previously characterized bHLH proteins. Pod-1 was most similar (60% amino acid identity) to paraxis (also (Murre et al., 1989a) . w designates hydrophobic amino acids. References for the compared sequences are as follows: paraxis (Quertermous et al., 1994; Blanar et al., 1995; Burgess et al., 1995 Burgess et al., , 1996 , scleraxis , dHAND (Srivastava et al., 1995) , eHAND Srivastava et al., 1995) , Hen1 (Brown et al., 1992) , MyoD (Davis et al., 1987) , myogenin (Edmondson and Olson, 1989) , NeuroD (Lee et al., 1995) , neurogenin (Ma et al., 1996). known as Meso1 or bHLH-EC2). Paraxis is a class B bHLH protein that is expressed in dorsal (paraxial) mesoderm and that is required for somite formation (Quertermous et al., 1994; Blanar et al., 1995; Burgess et al., 1995 Burgess et al., , 1996 . The sequences of Pod-1 and paraxis were identical at positions that are conserved in bHLH proteins (indicated by the consensus sequence in Fig. 2 ) or differed by a conservative amino acid substitution. Pod-1 was also similar (56% identity) to scleraxis, a homologue of paraxis that is expressed in cartilage and connective tissue . Pod-1 was 51% and 44% identical to dHAND and eHAND (Thing 1) which are bHLH proteins that are involved in cardiac development Srivastava et al., 1995) . However, Pod-1 does not contain the invariant proline in the basic region that is present in eHAND as well as the h/E(spl) proteins. There was less similarity (35-46% identity) between Pod-1 and the neurogenic bHLH proteins (Hen1, NeuroD, neurogenin) or the myogenic bHLH proteins (MyoD, myogenin). Outside of the bHLH domains, the sequence of Pod-1 was not similar to any previously characterized bHLH proteins. In particular, Pod-1 did not contain the WRPW motif at the carboxyl terminus that is characteristic of h/E(spl) proteins or the polyglutamine or polyproline stretches present in other bHLH proteins. Taken together, these results identified Pod-1 as a novel member of a recently described subfamily of bHLH proteins that have important roles in mesodermal development.
Comparison of Pod-1 with previously characterized bHLH proteins
Chromosomal mapping of Pod-1 in the mouse
The chromosomal location of Pod-1 in the mouse was determined using an interspecific backcross panel from The Jackson Laboratory (Rowe et al., 1994) . To date, more than 600 loci that span the genome have been mapped on this panel which can therefore be used to identify the location of new genes anywhere in the mouse genome. Genomic Southern blot analysis was performed to identify restriction fragment length polymorphisms (RFLPs) between an inbred strain of Mus musculus (C57BL/6J) and the wild mouse, M. spretus. This analysis showed that a Pod-1 cDNA hybridized to single restriction fragments following digestion with BglII, PstI, XbaI, EcoRI, MspI, TaqI, HindIII, and BamHI consistent with a single-copy gene. In addition, the length of the TaqI restriction fragment was 1.6 kb in C57BL/6J and 10.0 kb in M. spretus. The segregation of the informative TaqI RFLP was followed in an interspecific backcross between (C57BL/6J × M. spretus)F 1 hybrid females and C57BL/6J males. Ninety-four N 2 backcross progeny were genotyped, and the results were compared to previously mapped loci. Fig. 3 shows that Pod-1 (gene symbol Pod1) was very closely linked to D10Mit2, a microsatellite marker that was previously assigned to the proximal region of mouse Chromosome 10 (Rowe et al., 1994) . Among 94 meioses no recombination was detected between Pod1 and D10Mit2 (95% confidence interval 0-3.8 cM). D10Mit2 and Pod1 map to a region of mouse Chromosome 10 that is syntenic with human Chromosome 6q23-q24. The chromosomal location of Pod-1 is distinct from the related bHLH protein paraxis (Meso1) which was previously mapped to the distal region of mouse Chromosome 2 (Blanar et al., 1995) .
Northern blot analysis of Pod-1 expression in adult tissues and developing kidney
To examine the tissue distribution of Pod-1, we first performed northern blot analysis. Fig. 4A shows the results of hybridization of a human multiple tissue northern blot with a Pod-1 cDNA. To minimize possible cross-reactivity, a probe lacking the bHLH domain was used, and hybridization and washing were performed at high stringency. The human Pod-1 transcript was 1.3 kb, which was consistent with the length of the cloned cDNA. Pod-1 was most highly expressed in the lung, kidney, heart, and placenta. Lower levels of expression were observed in the pancreas. Even with longer exposure times, no expression of Pod-1 was detected in the brain, liver, or skeletal muscle. A similar pattern of expression was observed in the mouse (data not shown). Although Pod-1 was expressed in the adult kidney, the level of expression was considerably higher in the developing kidney. Fig. 4B shows the expression of Pod-1 in the developing mouse metanephros. In the mouse, development of the metanephros commences at 11.5 days post-coitus (d.p.c.) and continues for 1-2 weeks post-partum. Pod-1 was expressed in the metanephros at 13.5 d.p.c., which was the earliest developmental stage examined. Expression was maximal at 16.5 d.p.c. and persisted through the first week post-partum then was down-regulated in the adult kidney. These results demonstrated that the expression of Pod-1 in the kidney was developmentally regulated and corresponded to the period of active nephrogenesis.
Analysis of Pod-1 expression in mouse embryos by RNA in situ hybridization
To identify the cell types that expressed Pod-1 in the developing kidney and other tissues, we performed RNA in situ hybridization (ISH) using 33 P-labeled riboprobes.
These studies revealed that Pod-1 was expressed in two distinct cell lineages that are both of mesodermal origin: mesenchymal cells and visceral glomerular epithelial cells (podocytes). Fig. 5 shows the expression of Pod-1 in mouse embryos at 13.5 d.p.c., 14.5 d.p.c., and 16.5 d.p.c. At 13.5 d.p.c. and 14.5 d.p.c., Pod-1 was expressed in the developing kidney, lung, intestine, heart, adrenal gland, and pancreas. By 16.5 d.p.c., expression of Pod-1 had declined in most tissues but remained high in the kidney and lung. Hybridization with sense Pod-1 riboprobes produced no significant signal (not shown). Higher magnification images showed that Pod-1 was selectively expressed in mesenchymal cells at sites of epithelial-mesenchymal interaction in the developing kidney, lung, intestine, and pancreas. In the kidney (Fig. 5I,J) , Pod-1 was highly expressed in mesenchymal cells surrounding the ureteric bud and developing nephric structures but was excluded from the ureteric epithelium and tubular epithelial cells. Pod-1 was not highly expressed in nephrogenic mesenchyme at or near the ureteric bud tips (Fig. 5I ,J,M). Rather, Pod-1 was highly expressed in mesenchymal cells surrounding the stalks of the branching ureteric bud. These cells have a condensed appearance (as shown in Fig. 6A ,B) but are distinct from the nephrogenic mesenchyme. Similarly, in the intestine (Fig.  5C ) and lung ( Fig. 5F ) Pod-1 was highly expressed in mesenchymal cells underlying the developing epithelium but was excluded from the epithelial cell compartment itself. At 14.5 d.p.c., Pod-1 was also expressed at low levels in mesenchymal cells in the developing pancreas (Fig. 5E ) and hair follicles (data not shown).
In addition to mesenchymal cells, Pod-1 was expressed in visceral glomerular epithelial cells (podocytes) in the kidney. At 16.5 d.p.c. (Fig. 5K) , expression of Pod-1 in the mesenchyme was decreased, but Pod-1 was highly expressed in developing glomeruli. Fig. 5L shows the adult renal cortex in which the expression of Pod-1 was restricted to glomeruli. During kidney organogenesis, the development of the nephron progress through an orderly series of well-defined morphological stages termed the renal vesicle, S-shaped body, capillary-loop stage, and maturing glomerulus (Reeves et al., 1978; Abrahamson, 1991) . The renal vesicle consists of a uniform population of columnar epithelial cells surrounding a central lumen. Invagination of the renal vesicle produces the S-shaped body, which consists of the glomerular anlage and proximal and distal limbs that are the progenitors of the proximal and distal tubules. The capillary loop stage is recognized by the appearance of several capillary loops within the glomerular tuft. Final differentiation including formation of foot processes occurs at the maturing glomerulus stage. Fig. 5M shows that Pod-1 was highly expressed in the mesenchyme surrounding the stalk of the ureteric bud but was not expressed in the renal vesicle. Expression of Pod-1 in developing nephrons was first detected at the S-shaped body stage (Fig. 5N) . In the S-shaped body, Pod-1 was expressed in the glomerular anlage but was absent from the adjacent epithe- lial cells that will form the proximal and distal tubules. Within the glomerular anlage, Pod-1 was highly expressed in the presumptive podocyte layer adjacent to the vascular cleft but was not significantly expressed in endothelial cells within the vascular cleft. At the capillary-loop stage (Fig.  5O ), Pod-1 was expressed in developing podocytes that formed a C-shaped cap over the underlying glomerular endothelial and mesangial cells which did not express Pod-1. Pod-1 was not expressed in parietal epithelial cells that will form Bowman's capsule (Fig. 5L) . These results identified Pod-1 as a marker of developing and mature visceral glomerular epithelial cells. 
Antisense inhibition of Pod-1 in organotypic kidney culture
To begin examining the role of Pod-1 in kidney morphogenesis, we inhibited its expression in metanephric organ culture using antisense oligonucleotides. Metanephroi were isolated at 13.5 d.p.c. and cultured under conditions that permit continued growth and branching of the ureteric bud and induction of new epithelia. Cultured metanephroi were incubated with antisense Pod-1 oligonucleotides for 72 h then were examined by light microscopy. The contralateral metanephroi were incubated with sense oligonucleotides as negative controls. RT-PCR was performed to verify that incubation with antisense oligonucleotides resulted in inhibition of Pod-1 expression. Fig. 6G shows that a Pod-1 PCR product of the expected size (340 bp) was amplified from metanephroi that were incubated with sense oligonucleotides. In contrast, minimal PCR product was produced from metanephroi incubated with antisense oligonucleotides indicating that Pod-1 expression was inhibited. The inhibition of Pod-1 was specific since the expression of the housekeeping gene b-actin was equivalent in antisense and sense oligonucleotide-treated metanephroi. The expression of the homeobox gene Cux-1, which is also expressed in metanephric mesenchyme (Vanden Heuvel et al., 1996) , was also unaffected. Fig. 6 shows that growth of the ureteric bud and formation of glomeruli were observed in metanephroi treated with sense and antisense Pod-1 oligonucleotides, although some dysgenic nephron structures were present in the antisense oligonucleotide-treated explants (not shown). However, there was a marked reduction in mesenchymal cell condensation surrounding the branches of the ureteric bud in the antisense Pod-1 oligonucleotidetreated metanephroi (Fig. 6D,E) . Ultrastructural analysis verified that the mesenchymal cells did not undergo apoptosis but remained instead as loose mesenchyme (not shown). In contrast, mesenchymal cell condensation around the ureteric bud occurred normally in the presence of sense Pod-1 oligonucleotides (Fig. 6A,B) .
Mesenchymal cells surrounding the ureteric bud are thought to produce factors that are important for branching morphogenesis (Stuart et al., 1995; Pichel et al., 1996) . Accordingly, we studied the effect of antisense inhibition of Pod-1 on ureteric branching. Metanephroi were incubated with sense or antisense Pod-1 oligonucleotides then were stained with Dolichos biflorus agglutinin (DBA), a lectin that specifically labels the epithelium of the ureteric bud (Laitinen et al., 1987) . Fig. 6C shows that ureteric branching occurred normally in the sense oligonucleotide-treated explants, but in the antisense oligonucleotide-treated explants the number of secondary and fine branches was reduced (Fig. 6F) . Quantification of the number of branch points revealed that ureteric branching was inhibited by 40% in the antisense oligonucleotide-treated metanephroi compared with the sense controls ( Fig. 6H , P Ͻ 0.0001).
Discussion
Pod-1 belongs to a family of mesoderm-specific bHLH proteins
Pod-1 is a novel member of a recently-described subfamily of mesoderm-specific bHLH proteins. Previously identified members of this family include paraxis (Meso1, bHLH-EC2), scleraxis, eHAND (Thing1), and dHAND. Targeted mutagenesis has shown that these proteins have essential roles in the embryonic development of mesodermal tissues. Paraxis is expressed in paraxial mesoderm and is essential for somitogenesis (Burgess et al., 1995 (Burgess et al., , 1996 Blanar et al., 1995) . Scleraxis is expressed in the sclerotome of the somites and subsequently in cartilage and connective tissue . eHAND and dHAND are expressed in different domains within the developing heart and are required for cardiac morphogenesis (Srivastava et al., 1995 (Srivastava et al., , 1997 . The pattern of expression of Pod-1 is distinct from the other members of this family. Pod-1 is the first tissue-restricted (class B) bHLH protein to be identified in the kidney. In the developing kidney, Pod-1 is expressed in mesenchymal cells that are adjacent to the ureteric epithelium and in visceral glomerular epithelial cells. In the adult kidney, Pod-1 is expressed in the renal interstitium and in mature podocytes. Pod-1 is also expressed in the lung, intestine and pancreas. Within these organs, Pod-1 is highly expressed in mesenchymal cells that are derived from splanchnic mesoderm and that underlie the developing epithelium. In contrast, Pod-1 is excluded from the epithelial cell compartment which is derived from endoderm in these tissues. Thus, Pod-1 is the first example of a bHLH protein that is selectively expressed in mesodermallyderived mesenchymal cells at sites of epithelial-mesenchymal interaction during organogenesis.
Pod-1 is involved in mesenchymal-epithelial interactions in the developing kidney
Antisense inhibition of Pod-1 in the developing kidney inhibited mesenchymal cell condensation around the branching ureteric bud. Mesenchymal cell condensation at sites of epithelial-mesenchymal interaction is an early event in the embryonic development of many organs including the lung, pancreas, salivary gland, mammary gland, teeth and kidney (Saxén and Thesleff, 1992; Thesleff et al., 1995) . In these tissues, epithelial morphogenesis is dependent on signals from the underlying condensed mesenchyme. The mechanism of mesenchymal cell condensation is not wellunderstood but appears to involve growth factors such as TGFb1 and BMP4, and cell-matrix adhesion molecules such as syndecan-1 and tenascin-C (Thesleff et al., 1995) . Recently, the syndecan-1 promoter was shown to be activated by the Wilms' tumor protein WT-1, a transcription factor that is expressed in condensed mesenchyme in the developing kidney (Cook et al., 1996) . Expression of tenas-cin-C is increased in murine metanephric cells following stable transfection with Pod-1 (Quaggin et al., unpublished data) . Therefore, Pod-1 may regulate the expression of genes, such as tenascin-C, that mediate mesenchymal cell condensation at sites of mesenchymal-epithelial interaction.
The inhibition of ureteric branching in metanephroi treated with antisense Pod-1 oligonucleotides supports the involvement of metanephric mesenchymal cells in patterning of the renal collecting system. The antisense experiments suggest that expression of Pod-1 in the mesenchyme surrounding the ureteric bud may be necessary for kidney morphogenesis. Since Pod-1 is not expressed in the ureteric bud, the observed impairment in branching morphogenesis must be secondary to perturbations in the adjacent mesenchyme. These results are similar to mice with targeted disruption of BF-2, a winged-helix transcription factor that is expressed in stromal mesenchyme in the kidney. BF-2-deficient mice exhibit reduced branching of the renal collecting system which suggests that BF-2 regulates the production of mesenchymal factors that are essential for ureteric branching (Hatini et al., 1996) . Grobstein first showed that growth and branching of the ureteric bud in vitro were critically dependent on co-culture with metanephric mesenchyme (Grobstein, 1955) . More recent studies have shown that glial-cell-line-derived neurotrophic factor (GDNF) is produced by the metanephric mesenchyme and is required for ureteric growth and branching (Pichel et al., 1996) . GDNF binds to the c-ret receptor tyrosine kinase that is expressed in ureteric epithelial cells, and studies using targeted mutagenesis in mice have shown that c-ret is required for ureteric branching. Additional signaling molecules produced by metanephric mesenchyme, such as hepatocyte growth factor, also appear to be involved in branching morphogenesis in the kidney (Stuart et al., 1995) . Abnormalities of ureteric branching have also been observed in mice carrying targeted mutations of the a8 integrin gene which is expressed in metanephric mesenchymal cells (Müller et al., 1997) . Presently, it is not known whether Pod-1 affects integrin expression or the GDNF/cret or HGF/c-met signaling cascades. In addition to the kidney, Pod-1 is expressed in mesenchymal cells underlying epithelia in the developing lung, pancreas, and intestine. Each of these organs arises from epithelial-mesenchymal interactions in which branching and folding of the epithelium are dependent on inductive signals from the adjacent mesenchyme (Birchmeier and Birchmeier, 1993; Thesleff et al., 1995) . The pattern of expression of Pod-1 suggests that it may govern epithelial branching and related morphogenetic events in these organs as well.
Pod-1 is a marker of developing glomerular epithelial cells
Pod-1 is expressed in developing visceral glomerular epithelial cells (podocytes) in the kidney. Podocytes are mesodermally derived cells that are largely responsible for maintaining the glomerular filtration barrier between the blood and urinary space (Mundel and Kriz, 1995) . Podocytes are important clinically because abnormalities of their structure and function are associated with increased glomerular permeability and proteinuria. However, little is known regarding the genetic control of podocyte development, and only a few podocyte-specific markers have been identified. Pod-1 is selectively expressed in developing and mature podocytes but is absent from all other epithelial cell types in the nephron. Moreover, the onset of expression of Pod-1 coincides with glomerular epithelial cell differentiation: Presumptive podocytes first appear at the S-shaped body stage of nephron development and arise from typical columnar epithelial cells. As podocytes mature, they flatten and regain some characteristics of a mesenchymal cell such as expression of vimentin-containing intermediate filaments. During terminal differentiation, podocytes develop unique structural features such as foot processes and slit diaphragms that permit them to perform their highly specialized functions (Tassin et al., 1994; Mundel and Kriz, 1995) . Expression of Pod-1 is first detected in the S-shaped body, which is the earliest stage at which the glomerular and tubular primordia can be distinguished (Reeves et al., 1978; Abrahamson, 1991) . Within the glomerular anlage, Pod-1 is expressed in podocyte precursors adjacent to the vascular cleft. At later stages of glomerulogenesis (capillary loop and maturing glomerulus), expression of Pod-1 continues in podocytes as they undergo terminal differentiation. Thus, Pod-1 is the first podocyte-specific transcription factor whose onset of expression coincides with glomerular epithelial cell differentiation. These properties together with the known functions of other class B bHLH proteins suggest that Pod-1 may also have important roles in podocyte differentiation in addition to its role in epithelial-mesenchymal interactions.
Experimental procedures
Isolation of murine and human cDNA clones
To identify novel bHLH proteins that were expressed in the kidney, a text search of an EST database (Institute for Genome Research) was performed, and a partial-length human cDNA was obtained (accession no. R65626). The homologous murine cDNA (W08124) was identified by performing a BLASTN search of the dbEST database (GenBank). The full-length mouse cDNA was isolated using ligation-anchored PCR, which was performed as described previously (Igarashi et al., 1995) . The template for ligationanchored PCR was 1 mg of poly(A) + RNA from postnatal day 3 mouse kidney. PCR was performed using two genespecific primers (GGTTCCCAGACTCGCACCTCCA and CGGTTGGCGGTCACCACTTCCT) and an anchor-specific primer (Clontech). Thirty cycles of incubation at 94°C for 30 s, 58°C for 30 s, and 68°C for 4 min were performed.
To maximize fidelity, a mixture of Taq and Pwo polymerases was used (Boehringer-Mannheim). A 780-bp PCR product was gel purified, ligated into the plasmid pCR2.1 (Invitrogen), and sequenced. The full-length human cDNA was amplified from a fetal kidney library (Clontech) using two gene-specific primers (ACGACT-CTGGGAGTGGGGAAA and GCACTTGGACCAGCA-AGGCTT) that were designed from the sequences of the mouse cDNA and the partial-length human EST. A 1.1-kb PCR product was gel-purified, subcloned and sequenced. DNA sequencing was performed by the Keck Foundation Biotechnology Resource Laboratory at Yale using an Applied Biosystems 373A Stretch DNA Sequencer. The sequencing reactions utilized fluorescently-labeled dideoxynucleotides and Taq FS DNA polymerase in a thermal cycling protocol. DNA sequence analysis was performed using GCG software or MacVector version 5.0.
Chromosomal localization in the mouse
Chromosomal mapping of the mouse Pod-1 gene was performed using The Jackson Laboratory interspecific backcross panel BSB (Rowe et al., 1994) . This panel consists of genomic DNA from 94 N 2 progeny from a cross between (C57BL/6J × M. spretus)F 1 hybrid females and C57BL/6J males. Genomic DNA (5-10 mg) from the parental strains and backcross progeny was digested with restriction endonucleases, electrophoresed through 1% agarose gels, then transferred to nylon membranes. Southern blots were hybridized with a 32 P-labeled cDNA encoding mouse Pod-1 (nucleotides 646-1240). Hybridization was performed at 42°C in Church-Gilbert medium containing 100 mg/ml denatured salmon sperm DNA and radiolabeled probe (1 × 10 6 c.p.m./ml). Filters were washed in 2× SSC at room temperature for 20 min, and 0.1× SSC containing 0.5% SDS at 55°C for 20 min, then exposed for 8 days to Kodak X-Omat AR film at −70°C with a single intensifying screen. The segregation of informative RFLPs was compared to previously mapped loci, and recombination distances were calculated using the program Map Manager version 2.6.
Northern blot analysis
A multiple tissue northern blot containing 2 mg poly(A) + RNA from adult human tissues was purchased from Clontech and hybridized with a 32 P-labeled human Pod-1 cDNA (nucleotides 702-1062). Hybridization was performed for 1 h at 68°C in ExpressHyb hybridization solution (Clontech). The filter was washed in 2× SSC containing 0.05% SDS for 20 min at room temperature, then 0.1× SSC containing 0.1% SDS for 20 min at 68°C. The filter was exposed to Kodak BioMax film for 2 days at −70°C. Northern blot analysis of Pod-1 expression in the developing metanephros was performed as described previously (Vanden Heuvel et al., 1996) . Briefly, metanephroi were removed from mice at various developmental stages, and total RNA was prepared by homogenization in guanidinium isothiocyanate and CsCl ultracentrifugation. RNA (10 mg) was electrophoresed, transferred to nylon membranes, and hybridized with a 32 P-labeled mouse Pod-1 cDNA (nucleotides 646-1240). Hybridization was performed at 42°C in Church-Gilbert medium containing 30% formamide and 100 mg/ml denatured salmon sperm DNA. Filters were washed in 2× SSC for 20 min at room temperature, then 0.1× SSC containing 0.5% SDS for 20 min at 65°C. As a control for equal sample loading, northern blots were stripped and re-hybridized with pRGAPD-13 encoding rat glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
RNA in situ hybridization
33 P-labeled riboprobes were synthesized and in situ hybridization was performed as described previously (Vanden Heuvel et al., 1996) . The probe was derived from the 3′ end of mouse Pod-1 (nucleotides 645-1031) and did not include the bHLH domain. Antisense or sense riboprobes were transcribed from a linearized pBluescript plasmid using [a 33 P]UTP and T3 or T7 RNA polymerases, respectively. Mouse embryos were fixed in 4% paraformaldehyde, cryoprotected, then embedded in OCT compound and frozen. Cryosections (10 mm) were prepared and hybridized overnight with radiolabeled antisense or sense riboprobes, then washed as described previously. Sections were dipped in Ilford K5D emulsion, exposed in the dark at 4°C for 7 days, then developed with Kodak D-19. Slides were counterstained with methylene blue and azure A, then photographed with Kodak TMAX or Ektachrome 160T film.
Organ culture and antisense inhibition
Metanephric organ culture and incubation with antisense oligonucleotides were performed as described previously (Quaggin et al., 1997) . Metanephroi were microdissected from mouse embryos at 13.5 d.p.c. and grown on Cyclopore membranes at the air-medium interface in serum-free defined medium (DMEM/F12 supplemented with 5× MITO+). For each treatment with antisense and sense oligonucleotides, metanephroi from the same embryo were paired to control for any variability in gestational age. Antisense oligonucleotides (CCCGCTCACGAACATTGGC and AGCCAGTGGACATGTTTAG) were designed to target the translation start codon or basic region of Pod-1. As negative controls, sense oligonucleotides (GCCAATGTT-CGTGAGCGGG and CTAAACATGTCCACTGGCT) were synthesized to the identical regions. Phosphorothioate-coupled oligonucleotides were synthesized by the Yale Pathology Program in Critical Technologies then purified by HPLC. Oligonucleotides were pre-mixed with 80 ml cationic liposomes (Lipofectamine, Life Technologies) then added to the culture medium to a final concentration of 5 mM. Fresh oligonucleotides were added every 24 h, and the medium was changed once at 48 h. After culture for a total of 72 h metanephroi were fixed in 1.5% glutaraldehyde, embedded in epon, sectioned and stained with methylene blue and azure II as described previously (Quaggin et al., 1997) .
RT-PCR
Reverse transcription of RNA and PCR amplification of cDNA (RT-PCR) was performed using the rTth Reverse Transcriptase RNA PCR Kit from Perkin Elmer Cetus Instruments. Total RNA was purified from metanephroi using acid guanidinium thiocyanate-phenol-chloroform extraction. First strand cDNA synthesis was performed in a total volume of 20 ml containing 10 mM Tris-Cl (pH 8.3), 100 mM KCl, 1 mM MnCl 2 , 200 mM of each dNTP, 0.5 U of rTth DNA polymerase, 750 nM of an antisense gene-specific primer and 165 ng of RNA. Reverse transcription was carried out by incubation at 65°C for 9 min, followed by incubation at 70°C for 6 min. The reaction was stopped by placing the tubes on ice, and 80 ml of a PCR amplification reaction mix was added to give final concentrations of 8 mM Tris-Cl (pH 8.3), 4% glycerol, 80 mM KCl, 0.04% Tween-20, 0.6 mM EGTA, 1.5 mM MgCl 2 , and 150 nM gene-specific sense primer. PCR amplification was performed by incubation at 95°C for 120 s followed by 30 cycles of incubation at 95°C for 60 s and 60°C for 60 s. Samples were electrophoresed on a 3% NuSieve agarose gel, and products were visualized by ethidium bromide staining. The sequences of the PCR primers and the expected lengths of the products were: Pod-1 (AGGAGTTTGGAACTTCCAA-CGAGA, TCTCGTACTTGTCGTTGGCCAGGA, 340 bp); b-actin (AGCTGTGCTATGTTGCTCTAGACT, CAGA-CAGCACTGTGTTGGCATAGA, 257 bp); and Cux-1 (TCAGGCCGAGACCATTGCTCTGGA, TGGTTGGCT-CGTTCAAGGTCGGTCA, 258 bp).
Lectin staining
Metanephric explants were fixed for 30 min in 2% paraformaldehyde at 4°C, permeabilized for 30 min in 0.1% Saponin at 37°C, and incubated with 50 mg/ml fluorescein-conjugated Dolichos biflorus agglutinin (Vector Laboratories) in 0.1% Saponin for 1 h at 37°C. Metanephroi were washed three times in phosphate-buffered saline then photographed using a fluorescence microscope. The number of branching points per branch of the ureteric bud from 38 pairs of sense and antisense oligonucleotide-treated metanephroi were compared. Statistical analysis was performed using Student's two-tailed paired t-test.
Materials
Timed-pregnant mice (strain CD-1) were from Charles River Laboratories (Wilmington, MA). The morning of detection of copulatory plugs was designated 0.5 d.p.c., and gestational age was verified according to the criteria of Theiler. Research involving animals conformed to the stipulations of the Yale Animal Care and Use Committee. Restriction endonucleases and DNA-modifying enzymes were obtained from New England Biolabs, Promega, or Boehringer Mannheim. RNA polymerases were from Stratagene. Radionucleotides and nylon filters were from Amersham or Dupont NEN. Tissue culture media were from Life Technologies, Inc., and MITO+ serum extender was from Collaborative Biomedical Inc. Other reagents were of analytical or molecular biological grade from Sigma or Baker.
